Evidence map›Paper›PMID 20838637›Full record

ArticlePloS one2010

Dedifferentiation and proliferation of mammalian cardiomyocytes.

Yiqiang Zhang, Tao-Sheng Li, Shuo-Tsan Lee, Kolja A Wawrowsky, Ke Cheng, Giselle Galang, Konstantinos Malliaras, M Roselle Abraham, Charles Wang, Eduardo Marbán

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 202 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The multifaceted nature of endogenous cardiac regeneration.Frontiers in cardiovascular medicine · 2023
    Review
  17. The Cardiac Sarcomere and Cell Cycle.Current cardiology reports · 2022
    Review
  18. Article
  19. Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yiqiang ZhangHeart Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Tao-Sheng Li
Shuo-Tsan Lee
Kolja A Wawrowsky
Ke Cheng
Giselle Galang
Konstantinos Malliaras
M Roselle Abraham
Charles Wang
Eduardo Marbán
Cedars-Sinai Medical Center · USCity Of Hope National Medical Center · USJohns Hopkins University · US

Funding

Electrophysiology and Cell Biology of Cardiac Stem CellsR01HL083109 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MARBAN, EDUARDO · 2006 to 2014
$3.6M
NHLBI NIH HHS R01 HL083109NHLBI NIH HHS R01HL083109
6 · The paper itself

Abstract

backgroundIt has long been thought that mammalian cardiomyocytes are terminally-differentiated and unable to proliferate. However, myocytes in more primitive animals such as zebrafish are able to dedifferentiate and proliferate to regenerate amputated cardiac muscle. METHODOLOGY/PRINCIPAL

findingsHere we test the hypothesis that mature mammalian cardiomyocytes retain substantial cellular plasticity, including the ability to dedifferentiate, proliferate, and acquire progenitor cell phenotypes. Two complementary methods were used: 1) cardiomyocyte purification from rat hearts, and 2) genetic fate mapping in cardiac explants from bi-transgenic mice. Cardiomyocytes isolated from rodent hearts were purified by multiple centrifugation and Percoll gradient separation steps, and the purity verified by immunostaining and RT-PCR. Within days in culture, purified cardiomyocytes lost their characteristic electrophysiological properties and striations, flattened and began to divide, as confirmed by proliferation markers and BrdU incorporation. Many dedifferentiated cardiomyocytes went on to express the stem cell antigen c-kit, and the early cardiac transcription factors GATA4 and Nkx2.5. Underlying these changes, inhibitory cell cycle molecules were suppressed in myocyte-derived cells (MDCs), while microRNAs known to orchestrate proliferation and pluripotency increased dramatically. Some, but not all, MDCs self-organized into spheres and re-differentiated into myocytes and endothelial cells in vitro. Cell fate tracking of cardiomyocytes from 4-OH-Tamoxifen-treated double-transgenic MerCreMer/ZEG mouse hearts revealed that green fluorescent protein (GFP) continues to be expressed in dedifferentiated cardiomyocytes, two-thirds of which were also c-kit(+). CONCLUSIONS/SIGNIFICANCE: Contradicting the prevailing view that they are terminally-differentiated, postnatal mammalian cardiomyocytes are instead capable of substantial plasticity. Dedifferentiation of myocytes facilitates proliferation and confers a degree of stemness, including the expression of c-kit and the capacity for multipotency.

Indexed as

Cell DifferentiationCell ProliferationAnimalsCells, CulturedGATA4 Transcription FactorHomeobox Protein Nkx-2.5Homeodomain ProteinsMaleMiceMice, TransgenicMyocytes, CardiacRatsRats, Inbred WKYTranscription FactorsGATA4 Transcription FactorHomeobox Protein Nkx-2.5Homeodomain ProteinsNkx2-5 protein, mouseNkx2-5 protein, ratTranscription Factors

Identifiers

PMID20838637
PMCPMC2933247
OpenAlexW2044703255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.